Skip to content

Clinical Study on the Treatment of Posterior Circulation Ischemia Vertigo with the Six Qi Acupuncture Technique

Clinical Study on the Treatment of Posterior Circulation Ischemia Vertigo with the Six Qi Acupuncture Technique

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001291
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Circulation Ischemia Vertigo

Interventions

Control group:Conventional therapy
Treatment group:Conventional therapy + Acupuncture therapy

Sponsors

Jing'an District, Shanghai Pengpu Xincun Community Health Care Center Internet Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) It meets the Western medical diagnostic criteria for isolated vertigo due to post-circulatory ischemia and the traditional Chinese medicine diagnostic criteria for vertigo caused by wind-phlegm ascending to the brain. (2) The main symptoms include rotational dizziness or a feeling of swaying, as well as nausea, vomiting, balance disorders or blurred vision, etc. (3) The age range is from 45 to 90 years old (including 45 years old and 90 years old). (4) The patients voluntarily participated and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the above inclusion criteria; (2) Patients with vertigo caused by cerebral hemorrhage, intracranial tumors, and brain trauma, or patients with severe posterior circulation infarction, as confirmed by cranial magnetic resonance imaging (MRI) or cranial computed tomography (CT) examination; ; (3) Those who test positive on the cervical vertigo screening test, or the vestibular source screening test, or those with peripheral vertigo such as ear-origin or eye-origin vertigo after physical examination; (4) Those with severe diseases of the circulatory system, digestive system, tumors, blood system, etc.; (5) Pregnant or lactating women; (6) Those with mental disorders such as confusion or dementia who cannot cooperate; (7) Those who have participated or are currently participating in other drug-related clinical trials in the past month; (8) Those who are allergic or fearful of acupuncture needles.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy rate;

Secondary

MeasureTime frame
Transcranial Doppler Ultrasound;Dizziness Handicap Inventory;Blood fat;Coagulation function;C reactive protein;Interleukin 6;

Countries

China

Contacts

Public ContactLuying

Jing'an District, Shanghai Pengpu Xincun Community Health Care Center Internet Hospital

anqian_627@163.com18278106835

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026